UnitedHealth Group Accounts Receivable & Other decreased by 5.6% to $554.00M in Q3 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase may signal growth in business volume or potential collection delays, while a decrease indicates efficient cash conversion cycles.
This includes amounts owed to the firm by clients or counterparties for services rendered, trading settlements, or other...
Standard line item across financial services firms, though composition varies based on business mix.
accounts_receivable_net_and_other| Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $585.00M | $550.00M | $530.00M | $550.00M | $587.00M | $554.00M |
| QoQ Change | — | -6.0% | -3.6% | +3.8% | +6.7% | -5.6% |
| YoY Change | — | — | — | -6.0% | +6.7% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.